← United States · Coverage record
US · SEC FORM 4
SpyGlass Pharma, Inc.
SGP · Nasdaq · CIK 0001778922 · Healthcare · Biotechnology
INSIDER SIGNAL
0 qualifying P purchase groups
in the current 180-day scoring window
0 Form 4 transaction lines observed in the same window
0 sales · 0 option, withholding, award, gift or other lines
WHY NO ACTIVE SIGNAL?
Score anatomy
No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.
Why is there no score?
- No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
- Sales and other Form 4 activity remain visible as context and do not create a negative score.
Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.
Insider activity timeline
No Form 4 transaction event is present in the current 180-day window.
Purchase breadth, concentration & cluster buying
These modules activate when qualifying purchases enter the 180-day research window.
SIGNAL HISTORY
Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2026-02-09 · Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund III, L.P.; Shah Rajeev M..
Recent Form 4 activity
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
Market context
Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.
Short interest
Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.
- Shares short
- 1,253,724
- Previous report
- 1,229,711
- Avg daily volume
- 176,358
- Days to cover
- 7.1
FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.
Historical equity purchases
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-02-09 | Yang Rick | Purchase (P) | Common Stock | 937,500 | USD 16.00 | USD 15,000,000 | SEC filing ↗ |
| 2026-02-09 | Walker Paul Edward | Purchase (P) | Common Stock | 937,500 | USD 16.00 | USD 15,000,000 | SEC filing ↗ |
| 2026-02-09 | SANDELL SCOTT D | Purchase (P) | Common Stock | 937,500 | USD 16.00 | USD 15,000,000 | SEC filing ↗ |
| 2026-02-09 | Pardo Geoffrey B | Purchase (P) | Common Stock | 312,500 | USD 16.00 | USD 5,000,000 | SEC filing ↗ |
| 2026-02-09 | NEA 17 GP, LLC; NEA Partners 17, L.P.; New Enterprise Associates 17, L.P. | Purchase (P) | Common Stock | 937,500 | USD 16.00 | USD 15,000,000 | SEC filing ↗ |
| 2026-02-09 | Mathers Edward T | Purchase (P) | Common Stock | 937,500 | USD 16.00 | USD 15,000,000 | SEC filing ↗ |
| 2026-02-09 | Makhzoumi Mohamad | Purchase (P) | Common Stock | 937,500 | USD 16.00 | USD 15,000,000 | SEC filing ↗ |
| 2026-02-09 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund III, L.P.; Shah Rajeev M. | Purchase (P) | Common Stock | 3,690,000 | USD 16.00 | USD 59,040,000 | SEC filing ↗ |
| 2026-02-09 | Khan Bilal Arshad | Purchase (P) | Common Stock | 135,000 | USD 16.00 | USD 2,160,000 | SEC filing ↗ |
| 2026-02-09 | Florence Anthony A. Jr. | Purchase (P) | Common Stock | 937,500 | USD 16.00 | USD 15,000,000 | SEC filing ↗ |
| 2026-02-09 | Chang Carmen | Purchase (P) | Common Stock | 937,500 | USD 16.00 | USD 15,000,000 | SEC filing ↗ |
| 2026-02-09 | Behbahani Ali | Purchase (P) | Common Stock | 937,500 | USD 16.00 | USD 15,000,000 | SEC filing ↗ |
| 2026-02-09 | BASKETT FOREST | Purchase (P) | Common Stock | 937,500 | USD 16.00 | USD 15,000,000 | SEC filing ↗ |
| 2026-02-09 | Nielsen Kirk G. | Purchase (P) | Common Stock | 165,000 | USD 16.00 | USD 2,640,000 | SEC filing ↗ |
| 2026-02-09 | Klein Peter Justin; Nielsen Kirk G.; Vensana Capital I GP, LLC; Vensana Capital I, L.P. | Purchase (P) | Common Stock | 165,000 | USD 16.00 | USD 2,640,000 | SEC filing ↗ |
Form 4 evidence
70 transaction lines in the latest 365-day window; 70 in local history.
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-02-09 | Yang Rick | Purchase (P) | Common Stock | 937,500 | USD 16.00 | USD 15,000,000 | SEC filing ↗ |
| 2026-02-09 | Yang Rick | C (C) | Common Stock | 3,727,370 | USD — | USD — | SEC filing ↗ |
| 2026-02-09 | Walker Paul Edward | Purchase (P) | Common Stock | 937,500 | USD 16.00 | USD 15,000,000 | SEC filing ↗ |
Show recent Form 4 evidence (29 grouped rows)
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-02-09 | Yang Rick | Purchase (P) | Common Stock | 937,500 | USD 16.00 | USD 15,000,000 | SEC filing ↗ |
| 2026-02-09 | Yang Rick | C (C) | Common Stock | 3,727,370 | USD — | USD — | SEC filing ↗ |
| 2026-02-09 | Walker Paul Edward | Purchase (P) | Common Stock | 937,500 | USD 16.00 | USD 15,000,000 | SEC filing ↗ |
| 2026-02-09 | Walker Paul Edward | C (C) | Common Stock | 5,084,633 | USD — | USD — | SEC filing ↗ |
| 2026-02-09 | SANDELL SCOTT D | Purchase (P) | Common Stock | 937,500 | USD 16.00 | USD 15,000,000 | SEC filing ↗ |
| 2026-02-09 | SANDELL SCOTT D | C (C) | Common Stock | 5,084,633 | USD — | USD — | SEC filing ↗ |
| 2026-02-09 | Pardo Geoffrey B | Purchase (P) | Common Stock | 312,500 | USD 16.00 | USD 5,000,000 | SEC filing ↗ |
| 2026-02-09 | Pardo Geoffrey B | C (C) | Common Stock | 1,875,013 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-02-09 | NEA 17 GP, LLC; NEA Partners 17, L.P.; New Enterprise Associates 17, L.P. | Purchase (P) | Common Stock | 937,500 | USD 16.00 | USD 15,000,000 | SEC filing ↗ |
| 2026-02-09 | NEA 17 GP, LLC; NEA Partners 17, L.P.; New Enterprise Associates 17, L.P. | C (C) | Common Stock | 3,727,370 | USD — | USD — | SEC filing ↗ |
| 2026-02-09 | Mathers Edward T | Purchase (P) | Common Stock | 937,500 | USD 16.00 | USD 15,000,000 | SEC filing ↗ |
| 2026-02-09 | Mathers Edward T | C (C) | Common Stock | 3,727,370 | USD — | USD — | SEC filing ↗ |
| 2026-02-09 | Makhzoumi Mohamad | Purchase (P) | Common Stock | 937,500 | USD 16.00 | USD 15,000,000 | SEC filing ↗ |
| 2026-02-09 | Makhzoumi Mohamad | C (C) | Common Stock | 5,084,633 | USD — | USD — | SEC filing ↗ |
| 2026-02-09 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund III, L.P.; Shah Rajeev M. | Purchase (P) | Common Stock | 3,690,000 | USD 16.00 | USD 59,040,000 | SEC filing ↗ |
| 2026-02-09 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund III, L.P.; Shah Rajeev M. | C (C) | Common Stock | 4,331,117 | USD — | USD — | SEC filing ↗ |
| 2026-02-09 | Khan Bilal Arshad | Purchase (P) | Common Stock | 135,000 | USD 16.00 | USD 2,160,000 | SEC filing ↗ |
| 2026-02-09 | Florence Anthony A. Jr. | Purchase (P) | Common Stock | 937,500 | USD 16.00 | USD 15,000,000 | SEC filing ↗ |
| 2026-02-09 | Florence Anthony A. Jr. | C (C) | Common Stock | 5,084,633 | USD — | USD — | SEC filing ↗ |
| 2026-02-09 | Chang Carmen | Purchase (P) | Common Stock | 937,500 | USD 16.00 | USD 15,000,000 | SEC filing ↗ |
| 2026-02-09 | Chang Carmen | C (C) | Common Stock | 5,084,633 | USD — | USD — | SEC filing ↗ |
| 2026-02-09 | Behbahani Ali | Purchase (P) | Common Stock | 937,500 | USD 16.00 | USD 15,000,000 | SEC filing ↗ |
| 2026-02-09 | Behbahani Ali | C (C) | Common Stock | 5,084,633 | USD — | USD — | SEC filing ↗ |
| 2026-02-09 | BASKETT FOREST | Purchase (P) | Common Stock | 937,500 | USD 16.00 | USD 15,000,000 | SEC filing ↗ |
| 2026-02-09 | BASKETT FOREST | C (C) | Common Stock | 5,084,633 | USD — | USD — | SEC filing ↗ |
| 2026-02-09 | Nielsen Kirk G. | Purchase (P) | Common Stock | 165,000 | USD 16.00 | USD 2,640,000 | SEC filing ↗ |
| 2026-02-09 | Nielsen Kirk G. | C (C) | Common Stock | 2,597,552 | USD — | USD — | SEC filing ↗ |
| 2026-02-09 | Klein Peter Justin; Nielsen Kirk G.; Vensana Capital I GP, LLC; Vensana Capital I, L.P. | Purchase (P) | Common Stock | 165,000 | USD 16.00 | USD 2,640,000 | SEC filing ↗ |
| 2026-02-09 | Klein Peter Justin; Nielsen Kirk G.; Vensana Capital I GP, LLC; Vensana Capital I, L.P. | C (C) | Common Stock | 2,597,552 | USD — | USD — | SEC filing ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
Snapshot & identity
| Snapshot date | 2026-10-18 |
|---|---|
| Ranking version | US-v1.2 |
| Data quality | PASS ELIGIBLE · — |
| Ticker | SGP |
| CIK | 0001778922 |
| Sector | Healthcare |
| Industry | Biotechnology Yahoo Finance |
| SEC SIC | 3841 Surgical & Medical Instruments & Apparatus |
| Exchange | Nasdaq |
Data coverage
| Local Form 4 history | 70 transaction lines from 2026-02-09 to 2026-02-09 17 P purchase lines · 0 S sale lines · 53 other lines |
|---|---|
| SEC company submissions | Open SEC filings ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.